Nikolas Herold Selected Research

SAM Domain and HD Domain-Containing Protein 1

1/2021	Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
10/2018	Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nikolas Herold Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 01/2017
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022 - 01/2017
5	Infections 01/2019 - 12/2014
4	Neuroblastoma 01/2022 - 10/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2022
1	Lymphoma (Lymphomas) 02/2022
1	Bites and Stings (Sting) 02/2022
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 09/2020
1	Hematologic Neoplasms (Hematological Malignancy) 02/2017
1	Disease Progression 01/2017

Drug/Important Bio-Agent (IBA)

7	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2022 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2016
3	triphosphoric acid (triphosphate)IBA 03/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
3	NucleosidesIBA 07/2018 - 01/2017
3	AntimetabolitesIBA 07/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2022
2	SAM Domain and HD Domain-Containing Protein 1IBA 01/2021 - 10/2018
2	Cytostatic AgentsIBA 01/2021 - 02/2017
2	DeoxycytidineIBA 01/2020 - 02/2017
1	Biological ProductsIBA 03/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	InterferonsIBA 02/2022
1	RadiopharmaceuticalsIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	vesicular stomatitis virus G proteinIBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Complementary DNA (cDNA)IBA 10/2017
1	Arabinofuranosylcytosine TriphosphateIBA 01/2017
1	CTPaseIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Interferon Type IIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Capsid Proteins (Capsid Protein)IBA 01/2016
1	CytokinesIBA 01/2016
1	Dynamin IIIBA 12/2014

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 03/2022 - 01/2017
2	Radiotherapy 01/2022 - 01/2021
2	Immunotherapy 01/2021 - 07/2018
1	Stem Cell Transplantation 03/2022
1	Consolidation Chemotherapy 10/2018
1	Combination Drug Therapy (Combination Chemotherapy) 07/2018
1	Adjuvant Radiotherapy 10/2017